Performa Ltd (US)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.03K | Buy |
+300
| New | +$5.03K | ﹤0.01% | 36 |
|
|
2024
Q3 | – | Sell |
-385
| Closed | -$6.26K | – | 54 |
|
|
2024
Q2 | $6.26K | Sell |
385
-200
| -34% | -$3.25K | ﹤0.01% | 37 |
|
|
2024
Q1 | $8.25K | Hold |
585
| – | – | ﹤0.01% | 36 |
|
|
2023
Q4 | $6.11K | Hold |
585
| – | – | ﹤0.01% | 40 |
|
|
2023
Q3 | $5.97K | Hold |
585
| – | – | ﹤0.01% | 49 |
|
|
2023
Q2 | $4.41K | Hold |
585
| – | – | ﹤0.01% | 61 |
|
|
2023
Q1 | $5.18K | Hold |
585
| – | – | ﹤0.01% | 55 |
|
|
2022
Q4 | $5.34K | Hold |
585
| – | – | ﹤0.01% | 52 |
|
|
2022
Q3 | $5K | Sell |
585
-215
| -27% | -$1.84K | ﹤0.01% | 50 |
|
|
2022
Q2 | $6K | Buy |
800
+50
| +7% | +$375 | ﹤0.01% | 37 |
|
|
2022
Q1 | $7K | Sell |
750
-300
| -29% | -$2.8K | ﹤0.01% | 27 |
|
|
2021
Q4 | $8K | Buy |
1,050
+650
| +163% | +$4.95K | ﹤0.01% | 31 |
|
|
2021
Q3 | $4K | Buy |
400
+300
| +300% | +$3K | ﹤0.01% | 36 |
|
|
2021
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 46 |
|
|
2021
Q1 | $1K | Sell |
100
-50
| -33% | -$500 | ﹤0.01% | 36 |
|
|
2020
Q4 | $1K | Buy |
+150
| New | +$1K | ﹤0.01% | 36 |
|
|
2020
Q1 | – | Sell |
-15,000
| Closed | -$147K | – | 11 |
|
|
2019
Q4 | $147K | Sell |
15,000
-3,300
| -18% | -$32.3K | 0.14% | 6 |
|
|
2019
Q3 | $169K | Hold |
18,300
| – | – | 0.17% | 5 |
|
|
2019
Q2 | $169K | Buy |
+18,300
| New | +$169K | 0.17% | 5 |
|